Real-Time oxygen sensing in the heart: a surgical breakthrough in the making?
NCT ID NCT06084091
This trial is taking on new participants right now.
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This observational study tests a new spectroscopic device designed to measure oxygen levels in the heart muscle during open-heart surgery. The goal is to see if the device can safely record this data and how it relates to surgical events and patient parameters. Participants are adults aged 18-90 scheduled for open-heart surgery for coronary artery or heart valve disease. The study focuses on device safety and performance, not on treating the disease itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Myocardial spectrometric measurement device
- What this could lead to
- If successful, this could provide real-time oxygen monitoring during heart surgery, potentially improving surgical safety and patient outcomes.
- What could go wrong
- This is an early, small observational study focused on device safety and feasibility. It may not prove clinical benefit, and device-related adverse events are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients scheduled for open-heart operation
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Any 18 to 90-year-old patient scheduled for an open-heart operation * The ability to understand the study's objective and the risks involved. * Informed consent obtained, including the agreement to authorization to use the protected personal patient records according to privacy legislation. Exclusion Criteria: * Inability to obtain an informed consent form * Patients included as vulnerable population according to Finnish Medical Research Act, including retarded, pregnant women, nursing mothers, prisoners, or forensic patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Heart and Lung Center
RECRUITINGHelsinki, Uusimaa, 00029, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a less invasive valve replacement tame a failing aortic valve?
- Routine heart scans after stents: could they save lives?
- A simple foot massage might ease pain and improve sleep after heart surgery
- Can combining two heart scans reveal more about clogged arteries?
- Can an mRNA vaccine shield the most vulnerable from RSV?
- Can a 16-Hour fast supercharge heart rehab?